EPHESUS Post-MI Eplerenone Response Score
- EPHESUS Post-MI Eplerenone Response Score: explanation and clinical context
This tool implements two things: (1) an objective eligibility check based on the original EPHESUS trial inclusion criteria — specifically enrollment 3–14 days after acute myocardial infarction (MI) with left ventricular ejection fraction (LVEF) ≤40% and either signs/symptoms of heart failure or diabetes — and (2) an exploratory, unvalidated response index that weights several clinical features commonly associated with higher event risk and with observed subgroup/biomarker responses in post-hoc EPHESUS analyses. The original EPHESUS randomized trial demonstrated that initiation of eplerenone (25 mg daily, titrated) in appropriately eligible post-MI patients produced roughly a 15% relative reduction in all-cause mortality compared with placebo. This calculator does not attempt to produce a validated individual absolute mortality estimate; rather, it (A) confirms whether a patient matches the trial population and (B) provides an exploratory point index to help clinicians identify patients whose baseline characteristics resemble higher-risk subgroups that have been associated with larger absolute event rates in published analyses. Use this tool as an adjunct to clinical judgment; decisions about starting mineralocorticoid receptor antagonists should include assessment of renal function, potassium, concomitant therapies (ACEi/ARB), blood pressure, and monitoring capability.
Reference:
Pitt B, et al. Eplerenone, a Selective Aldosterone Blocker, in Patients with (post-MI) Heart Failure — EPHESUS (primary trial report). NEJM 2003. Additional EPHESUS analyses and biomarker substudies (mortality timing, PIIINP predictors, timing of initiation) inform subgroup insights and monitoring recommendations. See: Pitt et al. NEJM 2003; Pitt et al. 2005 EPHESUS 30-day analysis; Stienen et al. (biomarker substudy) for predictors of biochemical response.
Discussion
No discussions yet. Be the first to comment.
Create Note
Notes are stored privately on your device only. No login required. Nothing is uploaded or shared.